Fundraising Fox
/Companies
Sign in

Acuamark Dx

New York, US · 1 known investors

Find your way into Acuamark Dx

Sign up to see every warm intro you have to Acuamark Dx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Acuamark Dx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring. It aims to make frequent, recurring cancer signal monitoring a standard part of primary care.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Founders & leadership

BPBernard Peperstraete
Bernard PeperstraeteCo-Founder and CEOBernard Peperstraete is co-founder and CEO of Acuamark Dx, a molecular diagnostics company developing blood-based cancer detection technology. He previously led ACT Biotech, a cancer pharmaceutical company acquired by Eddingpharm, and spent nearly a decade in healthcare venture capital as a partner at NGN Capital, following earlier roles at Novartis, Bristol Myers & Squibb, and Tan Tock Seng Hospital in Singapore, with an MBA from Harvard and training in tropical medicine.

Investors · 1

Related companies · 1

NaverisNaveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers. The company's flagship NavDx test uses proprietary technology to detect tumor tissue-modified viral HPV DNA in blood plasma, offering high sensitivity and specificity for cancer surveillance.

Companies working in the same space as Acuamark Dx.

Frequently asked questions

What does Acuamark Dx do?
AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring. It aims to make frequent, recurring cancer signal monitoring a standard part of primary care.
Who founded Acuamark Dx?
Acuamark Dx was founded by Bernard Peperstraete.
Who are Acuamark Dx's investors?
Acuamark Dx's investors include 1955 Capital.
Where is Acuamark Dx headquartered?
Acuamark Dx is headquartered in New York, US.